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Introduction
Treating patients with trophic ulcer (TU) in lower 
extremities with venous etiology (VE) is a complicated 
socio-medical and economic problem. Prevalence of 
‘venous’ TU in the adult working-age population of 
the Russian Federation is 1%-2%, it occurs more often 
in female than in male, in 0.3% of TU of VE cases, the 
healing process takes a very long time with repeated 
recurrence.1-4
Despite the advances of modern medicine, in particular, 
phlebology, the TU incidence rate has remained consistent 
over the past 20 years. There is a clear tendency towards 
the rejuvenation of this contingent of patients; it increases 
up to 4%-5% with age (in patients over 65 years old), and 
the radical elimination of the disease can be achieved only 
in every tenth patient.1 The problem is exacerbated by the 
presence of concomitant pathology.5 
The main factors affecting patients’ quality of life 
with venous TU include a pain syndrome (80% of 
patients), resulting in insomnia (74% of patients), 
significant everyday inconveniences associated with 
hygiene procedures (90% of patients) and a selection of 
comfortable shoes (78%). Under the influence of these 
factors, psychological problems occur in the majority 
of patients. It was found that 26% of patients suffering 
from TU experience overwhelming fear to hurt their legs 
when playing games with children, 34% of them fear pets, 
another 27% cease communicating with their friends and 
colleagues. Only 3% TU patients have active sex life, most 
of them retaining normal potency. This has a negative 
impact on family relations and is a cause of divorce in 47% 
of cases.6
The cost of treating venous TU can vary within wide 
limits and depends on the technology used. In the 
countries of the European community, the closure of one 
TU as an outpatient procedure costs 800-1500 euros, and 
supporting anti-relapse treatment makes 100-150 euros 
per month. In the United States, for closure of venous TU 
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within 3 months, direct medical costs reach US$1500-
2000. Prolongation of the treatment for a longer time 
results in increased cost up to US$30 000 or more. The 
total material damage, depending on the social status 
of the patient, can reach several hundred thousands of 
dollars. The annual costs on the health care system in the 
United States and Western Europe account for up to 2.5 
billion euros. In Russia, the direct costs of treating one 
case of venous TU can reach 160-250 euros in the clinic, 
and exceed 325 euros in hospital.7-9
Great prevalence of TU of VE, peculiarities of the disease’s 
progress and differences of wound healing process 
from other types of skin abnormalities, a tendency to 
relapse, poor efficiency of the existing therapies, the 
enormous economic damage caused by disability and 
frequent incapacitation of patients, as well as the need for 
additional care for elderly patients, dictate the necessity 
to find better, pathogenetically substantiated methods to 
treat this disease.10
Currently, the main treatment trends for patients 
with venous TU include (1) the correction of venous 
hemodynamics by surgery, sclerotherapy and elastic 
compression; (2) medication effects on venous tonus, 
micro-circulation and lymphatic drainage; (3) topical 
treatment, the nature of which is determined by the 
stage of the wound healing process, particularly applying 
physical factors, that is a subject of many works.11,12
There are numerous reports in literature referring to 
topical application of various kinds of low level laser 
therapy (LLLT), mainly in continuous mode of the red 
spectrum (633-635 nm) and in pulsed mode of infrared 
(IR) spectrum (890-904 nm) when treating TU. The 
abilities of LLLT non-invasive irradiation to restore the 
elasticity of the cell membranes, to normalize lymph and 
hemomicrocirculation in affected area, and to restore the 
regulating and sanogenetic functions of tissues, organs 
and the entire body by activating enzyme systems and 
metabolism, are very useful in the treatment of patients 
with venous TU.13-16
However, poor efficiency of the known methods of treating 
patients with TU necessitates the search for new ways and 
modes of laser therapy (LT) based on a comprehensive 
approach. Application of physical therapy, primarily with 
the use of LLLT, capable of influencing various stages in 
the pathogenesis of the disease, allows a high therapeutic 
effect in many cases, while ensuring systemic response of 
the patient’s body with the proper exposure procedure. 
LT methods for patients with TU of VE can be divided 
into 2 types: topical exposure and intravenous laser blood 
irradiation (ILBI). However, the available techniques 
are not sufficiently perfect, which is demonstrated by a 
rather large number of negative results of treatment or 
its minimal effect. This determined the relevance of the 
present study.
The objective of this study is to improve the results of 
outpatient treatment of patients with VE TU of lower 
extremities through the application of LLLT with different 
wavelengths.
Methods 
This study was performed as a clinical trial (Clinical Trials.
gov; Identifier: NCT03104985). During a longitudinal 
study, a group of patients was followed up in the period 
of complete or partial recovery. The analysis of the results 
of outpatient examination and treatment of 68 patients 
with venous TU, from 2013 to 2015, observed in the City 
Polyclinic of “Tula Municipal Clinical Hospital №2” was 
carried out.
The group of patient consisted of 50 (73.5%) women 
and 18 (26.5%) men. Patients’ age varied from 39 to 
78 years old. A mean age was 57.2 ± 0.5 years. Patients 
were examined as follows: general clinical methods 
of investigation (complete blood count, clinical urine 
analysis, biochemical blood assay, including glucose test, 
blood coagulation system test, culture and sensitivity 
tests of the ulcer defect surface) and instrumental 
investigations (ultrasonic Doppler examination [USDG], 
the measurement of the TU size with the calibration 
ruler).
Duration of the disease was above 5 years in 27 patients 
(39.7%) and less than 5 years in 41 patients (60.3%). There 
were 47 (69.1%) patients with varicose disease and 21 
(30.4%) patients with post-thrombophlebitic disease.
International classification of lower extremity chronic 
venous disorders (СЕАР) was used as a clinical 
classification of chronic venous insufficiency (CVI). In 
our survey, all patients had CVI Stage 6 (S6) in compliance 
with СЕАР.17
TU were localized over the medial ankle in 40 (58.8%) 
patients, over the lateral malleolus in 18 (26.5%) patients, 
in the combination of contralateral surfaces in 10 (14.7%). 
The disease recurrence was identified in 39 (57.3%) 
patients when they visited the clinic. Ulcer defects sized 
below 5 cm2 in 32 (47%) patients; from 5 to 10 cm2 in 28 
(41.2%) and from 10 to 25 cm2 in 8 (11.8%). 
Depending on the applied treatment method, patients 
were divided into 2 groups (Table 1).
Group 1 was represented by 34 (50%) patients who 
underwent conventional therapy. It included:
- An elastic compression of lower extremities (elastic 
bandages or compression hosiery of class 2).
- Pharmacotherapy: to improve venous tonus the 
following drugs were used: Anavenol, Aescusan, 
Glyvenol; lymphatic drainage function was improved 
using drugs of the benzopyrone group, including 
Troxevasin and Venoruton. In order to eliminate micro-
circulation disturbances and regulate hemorheology, 
Trental, aspirin and Ticlid (ticlopidine) were used. 
Nonsteroidal anti-inflammatory drugs (Nimesil, OKI), 
various ointments containing heparin, corticosteroids, as 
well as nonsteroidal anti-inflammatory drugs were used 
to stop inflammation. Antibiotic therapy of ulcer defect 
was administered in accordance with the sensitivity after 
determining microflora by culture inoculation
- Topical treatment was administered according to 
the general surgical rules: in the presence of purulent 
discharge (phase I of the wound healing process), 
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bandaging with antiseptic solutions (1% iodopiron 
solution, 0.1% chlorhexidine solution) and hydrophilic 
ointments (levosin, levomecol) were applied. In phases 
II and III, after ulcer cleansing, the treatment was 
aimed toward stimulating the granulation and marginal 
epithelization development. For this purpose, we used the 
preparations based on hyaluronic acid (Curiozin).
To carry out LT, the physiotherapeutic device LASMIK 
was used (Registration Certificate in Russia № RZN 
2015/2687 dated 25.05.2015). External exposure and ILBI 
were included in a daily complex of standard therapy. 
External exposure was conducted on the 1-4 affected 
area during one session for 2 minutes per zone in pulsed 
mode, light pulse duration of 100-130 ns, with wavelength 
635 nm, by a matrix emitter consisting of 8 laser diodes 
with a surface area of 8 cm2, at a distance of up to 7 
cm, with pulsed power of 40 W. ILBI was conducted in 
continuous mode with wavelength between 365-405 
nm (UV-spectrum) and 520-525 nm (green spectrum) 
alternately, during 12 daily treatment sessions according 
to the scheme: 
−	 Session 1 – 365-405 nm, power 1-2 mW, exposure 2 
minutes; 
−	 Session 2 – 520-525 nm, power 1-2 mW, exposure 5 
minutes;
−	 Session 3 – 365-405 nm, power 1-2 mW, exposure 2 
minutes;
−	 Session 4 – 520-525 nm, power 1-2 mW, exposure 5 
minutes;
−	 Session 5 – 365-405 nm, power 1-2 mW, exposure 2 
minutes;
−	 Session 6 – 520-525 nm, power 1-2 mW, exposure 5 
minutes;
−	 Session 7 – 365-405 nm, power 1-2 mW, exposure 2 
minutes;
−	 Session 8 – 520-525 nm, power 1-2 mW, exposure 5 
minutes;
−	 Session 9 – 365-405 nm, power 1-2 mW, exposure 2 
minutes;
−	 Session 10 – 520-525 nm, power 1-2 mW, exposure 
5 minutes;
−	 Session 11 – 365-405 nm, power 1-2 mW, exposure 
2 minutes;
−	 Session 12 – 520-525 nm, power 1-2mW, exposure 
5 minutes.
Patients in the control group were representative by age, sex, 
prevalence of lesions and the presence of comorbidities. 
Patients were distributed by random sampling; simulation 
of laser exposure was not performed. 
Results and Discussion
Evaluation of clinical treatment results showed that a 
slight dynamics of changes in the clinical picture was 
identified in patients with venous TU of group 1, who 
received only conventional treatment. After 14 days of 
treatment, edema of shank reduced only in 9 (26.5%) 
patients, and the pain stopped only in 7 (20.6%) patients.
In group 2, where in addition to conventional therapy, 
LLLT was performed according to the combined 
procedure, in contrast to the patients’ group 1, who 
received only conventional treatment, pain reduction in 
the lower extremities and even much faster decrease in 
inflammatory phenomena in the TU area were noted in 
5-7 days. Thus, surrounding tissue hyperemia persisted 
for 3-3.5 days, and infiltration around the edges of TUs 
remained for 4-4.5 days. Key indicators of wound healing 
process dynamics in patients with venous TU are given 
in Table 2.
As follows from the table data, in the group treated by 
conventional method, average TU cleansing time was 9.8 
± 0.2 days, generation of granulation tissue was identified 
in 10.3 ± 0.8 days and а healing (50% epithelialization) in 
28.1 ± 1.4 days. 
In the second group, the average time of cleansing from 
purulo-necrotic masses, granulation occurrence and ulcer 
epithelialization took, respectively: 6.4 ± 0.4, 7.1 ± 0.6 and 
12.8 ± 1.6 days. 
Compared to the patients of the first group, application 
of the developed technique for treating TU in patients 
with CVI of lower extremities promoted time reduction 
in ulcer cleansing by 1.5, granulation occurrence by 1.4 
times, wound healing (50% epithelialization) by 2.2 times.
Conservative treatment was applied for patients 
with venous TU either as a preparation for surgical 
interventions aimed at correcting venous circulation of 
lower extremities, or as the main therapy, when there 
were contraindications to surgery or patients’ categorical 
refusal of the operation. 
The treatment results were evaluated after 6 months. 
Clinical dynamics were characterized by a more 
pronounced improvement in overall health, decrease in 
feeling of ‘tiredness’ in legs, reduced edema of shanks 
and feet in patients with venous TU in 6 months after 
treatment in group 2, which included external exposure 
with wavelength of 635 nm and ILBI with wavelength 
of 365-405 nm (UV-spectrum) and 520-525 nm (green 
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spectrum). The clinical picture of the first group 
corresponded to that prior to the therapy course.
In our opinion, the results of healing venous TU in 
groups are indicative. Thus, among patients receiving 
only conventional therapy, TU healing in 6 months was 
identified in 11 (32.3%) patients. Ulcer epithelialization 
occurred in 28 (82.3%) patients receiving conventional 
therapy and LT with external exposure and ILBI with 
wavelength of 365-405 nm (UVA-spectrum) and 520-525 
nm (green spectrum).
Thus, it is shown that the proposed method allows to carry 
out more effective treatment of patients with TU of VE, 
reduce time of healing, and to stimulate quite pronounced 
and persistent adaptive physiological response, that 
prevents TU relapse development. 
Conclusion
The new method of treating patients with TUs of 
VE using low level laser irradiation contributes to 
reduce time periods for wound surface cleansing from 
purulo-necrotic masses, stimulates proliferation and 
epithelialization processes by 2-2.7 times, compared with 
the conventional method, which allows improvement of 
treatment results for this group of patients, reducing time 
of ulcer healing, lowering the incidence of incapacitation 
and social adaptation costs.
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Table 2. Key Indicators of Wound Healing Process Progression in the Surveyed Groups
Patient Groups
Average Time (in days) Wound Healing (100% 
Epithelialization) in 6 Months, 
No. (%)Wound Surface Cleansing Granulation Occurrence 
Wound Healing (50% 
Epithelialization)
Group 1 (n = 34) 9.8 ± 0.2 10.3 ± 0.8 28.1 ± 1.4 11 (32.3)
Group 2 (n = 34) 6.4 ± 0.4a 7.1 ± 0.6a 12.8 ± 1.6a 28 (82.3)
a Statistically significant difference  of groups 1 and 2 (P < 0.05).
